色色色AV免费电影,av天堂影音先锋在线,风韵犹存的熟妇出轨在线,国产精品视频一区二区三区

掃碼關注公眾號           掃碼咨詢技術支持           掃碼咨詢技術服務
  
客服熱線:400-901-9800  客服QQ:4009019800  技術答疑  技術支持  質量反饋  關于我們  聯系我們
国产精品免费一区二区三区四区,天天影视欲香欲色成人网,久欠精品免费性爱视频
首頁 > 產品中心 > 一抗 > 產品信息
Anti-PD-1 & VEGF Reference Antibody (Ivonescimab Biosimilar) (BIO1019SM)  
訂購熱線:400-901-9800
訂購郵箱:sales@bioss.com.cn
訂購QQ:  400-901-9800
技術支持:techsupport@bioss.com.cn
100ug/詢價
1mg/詢價
5mg/詢價
大包裝/詢價

產品編號 BIO1019SM
英文名稱 Anti-PD-1 & VEGF Reference Antibody (Ivonescimab Biosimilar)
別    名 PDCD1 / PD-1 / CD279 & VEGF; Ivonescimab  
抗體來源
克隆類型 Monoclonal
交叉反應 Human
產品應用
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理論分子量 201.12kDa
性    狀 Lyophilized
亞    型 IgG-ScFv
純化方法 Protein A
緩 沖 液 100 mM Pro-Ac 20mM Arg pH 5.0
保存條件 -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions;Avoid repeated freeze-thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
產品介紹
產品圖片
Co-incubation of Ivonescimab with VEGF protein, then with the addition of VEGF-NF-AT-HEK293 cells and incubated for 6 hours. Bright-Lite was used to detect the fluorescent signal. As shown in fig, Ivonescimab can neutralize VEGF-165, and the IC50 was 7.957 nM.
Co-incubation of Ivonescimab with PD-1-NF-AT-Jurkat and CD3L-huPD-L1-CHO-K cells and incubated for 6 hours. Bright-Lite was used to detect the fluorescent signal. As shown in fig, Ivonescimab was able to block the PD-1/PD-L1 signaling pathway, and the EC50 was 7.957 nM.
Ivonescimab bound to huPD-1-Jurkat cells, and then rebounded to fluorescent secondary antibodies(Anti-human IgG, Fcγ PE) , and test by flow cytometry. As shown in fig, Ivonescimab bound to huPD-1-Jurkat cells, and the EC50 was 6.274 nM.
Ivonescimab bound to VEGFA protein, and then rebounded to secondary antibodies(Anti-human-IgG-Fc-HRP) , and read OD450. As shown in fig, Ivonescimab bound to huVEGFA-His, and the EC50 was 0.021 nM.
Ivonescimab bound to PD-1 protein, and then rebounded to secondary antibodies(Anti-human-IgG-Fc-HRP) , and read OD450. As shown in fig, Ivonescimab bound to huPD-1-His, and the EC50 was 0.051 nM.
The purity of Anti-PD-1 & VEGF Reference Antibody (Ivonescimab)is 98.33%, determined by SEC-HPLC.
Anti-PD-1 & VEGF Reference Antibody (Ivonescimab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The detected molecular weight of Anti-PD-1 & VEGF Reference Antibody (Ivonescimab) is 201.13 kDa.
版權所有 2004-2026 www.51putizi.com 北京博奧森生物技術有限公司
通過國際質量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫療器械-質量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網安備110107000727號